Scrolling Text
Welcome to 4th Global Pharmacovigilance Congress: June 20–21, 2026

Agenda

4th Global Pharmacovigilance Congress 2026

Global Voices: Safer Medicine

📍 India | June 20–21, 2026
🎤 30 Global Speakers


🗓️ DAY 1 | June 20, 2026

Global Alignment & Regulatory Excellence

08:30 – 09:30

Registration & Networking Breakfast


09:30 – 10:15

Inaugural Session & Opening Keynote

Theme: Global Voices, Safer Medicine

  • The evolving global pharmacovigilance landscape
  • Shared responsibility for patient safety

🔹 Track 1: Global Regulatory Harmonization

(ICH | WHO | EMA | FDA | CDSCO)

10:15 – 11:45

Session 1: Harmonizing Global Pharmacovigilance Systems

  • ICH E2 series: current status and future direction
  • WHO global PV initiatives and international collaboration
  • Regional regulatory convergence and divergence

Format: Expert talks + panel discussion


11:45 – 12:00

☕ Coffee Break


🔹 Track 2: Risk Management & Benefit–Risk Evaluation

(EMA | FDA | ICH)

12:00 – 13:30

Session 2: From Risk Identification to Risk Minimization

  • Risk Management Plans (RMPs): expectations and best practices
  • Benefit–risk evaluation across the product lifecycle
  • Case studies in safety decision-making

13:30 – 14:30

🍽️ Networking Lunch


🔹 Track 3: Signal Detection, Data Analytics & RWE

(FDA | EMA | WHO)

14:30 – 16:00

Session 3: Signal Detection in the Era of Big Data

  • Traditional vs advanced signal detection methodologies
  • Role of real-world evidence in pharmacovigilance
  • Data quality, validation, and regulatory acceptance

16:00 – 16:15

☕ Tea Break


🔹 Panel Discussion (Cross-Track)

16:15 – 17:30

Panel: Global Challenges in Pharmacovigilance Compliance

  • Regional inspection trends
  • Common compliance gaps and CAPA strategies
  • Building sustainable PV systems

17:30

Day 1 Wrap-Up & Networking



🗓️ DAY 2 | June 21, 2026

Digital Transformation, Compliance & Future Readiness


🔹 Track 4: Pharmacovigilance Inspections, Audits & Compliance

(FDA | EMA | CDSCO)

09:30 – 11:00

Session 4: Inspection-Ready Pharmacovigilance Systems

  • Regulatory inspection expectations
  • Common inspection findings and learnings
  • Audit preparedness and documentation best practices

11:00 – 11:15

☕ Coffee Break


🔹 Track 5: Digital & Future Pharmacovigilance

(ICH | FDA | EMA)

11:15 – 12:45

Session 5: Digital Transformation of Drug Safety

  • AI and automation in PV operations
  • Intelligent signal detection systems
  • Future regulatory perspectives on digital PV

12:45 – 13:45

🍽️ Lunch Break


🔹 Special Focus Track: Patient-Centric & Public Health Pharmacovigilance

(WHO | CDSCO)

13:45 – 15:00

Session 6: Patient Safety and Public Health Impact

  • Patient reporting and engagement strategies
  • Vaccine safety and mass immunization programs
  • Pharmacovigilance in emerging markets

15:00 – 15:15

☕ Tea Break


🔹 Closing Plenary

15:15 – 16:30

Future of Global Pharmacovigilance: Roadmap to 2030

  • Global collaboration and innovation
  • Regulatory expectations of the future
  • Closing keynote and congress takeaways

16:30

Congress Closing & Certificate Distribution

Organizing Team

The Global Pharmacovigilance Congress 2026 is curated and delivered by a dedicated team of professionals committed to advancing drug safety, regulatory excellence, and patient protection worldwide.

Our organising team brings together expertise from pharmacovigilance, regulatory affairs, clinical research, quality assurance, public health, and scientific event management. With a shared vision of fostering global collaboration, the team works closely with subject-matter experts, academic institutions, and industry stakeholders to ensure a high-quality, ethical, and impactful scientific programme.

Abstract Template and Award Nomination form

1781929800

  days

  hours  minutes  seconds

until

4th Global PV Congress 2026